CSTK - ETF AI Analysis
Top Page
Invesco Comstock Contrarian Equity ETF (CSTK)
Rating:71Outperform
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has delivered strong gains so far this year and over the past few months, showing solid recent momentum.
Broad Sector Diversification
Holdings are spread across many sectors, including financials, health care, technology, and energy, which helps reduce the impact of weakness in any single industry.
Multiple Strong Top Holdings
Several of the largest positions, such as Cisco, CVS Health, State Street, Chevron, and Merck, have shown strong performance, supporting the fund’s overall returns.
Negative Factors
High U.S. Concentration
With almost all assets invested in U.S. companies, the fund offers little geographic diversification and is heavily tied to the U.S. market.
Financial Sector Heavy Weighting
A large allocation to financial stocks means the ETF could be more sensitive to problems in banks and other financial firms.
Not All Top Holdings Are Performing Well
Some key positions, such as Wells Fargo, have shown weak performance, which can drag on the fund’s overall results.
CSTK vs. SPDR S&P 500 ETF (SPY)
AUM182.82M
RegionGlobal
Expense Ratio0.35%
Beta0.67
IssuerInvesco
Inception DateMay 07, 2025
Dividend YieldN/A
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume5,237
30 Day Avg. Volume7,917
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
39.23Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering58
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
CSTK Summary
The Invesco Comstock Contrarian Equity ETF (CSTK) is an actively managed fund that looks for undervalued companies across the total stock market, mainly in the U.S. It doesn’t track a set index, but instead follows a value and contrarian theme, meaning it focuses on stocks that may be out of favor but have solid long-term potential. Its holdings span many sectors, including financials, health care, and technology, with well-known names like Bank of America and Alphabet (Google). Investors might choose CSTK for diversification and potential long-term growth, but should know its share price can go up and down with the broader stock market and value stocks may stay out of favor for long periods.
How much will it cost me?The Invesco Comstock Contrarian Equity ETF (CSTK) has an expense ratio of 0.35%, meaning you’ll pay $3.50 per year for every $1,000 invested. This is slightly higher than average because it’s actively managed, which involves more research and decision-making compared to passively managed funds that track an index.
What would affect this ETF?The CSTK ETF could benefit from a global economic recovery, which may boost undervalued companies across sectors like financials, healthcare, and technology, where it has significant exposure. However, rising interest rates or regulatory changes in key sectors like financials and healthcare could negatively impact its holdings, while global economic uncertainty might weigh on its contrarian investment strategy. Its focus on undervalued companies provides potential for growth but also carries risks if market conditions remain unfavorable.
CSTK Top 10 Holdings
CSTK’s story is a contrarian mix where steady value names do much of the heavy lifting while a few laggards tug at the reins. On the upside, Microsoft and Alphabet keep the tech engine humming, with Merck and State Street rising and adding dependable ballast from health care and financials. Chevron’s recent strength in energy also helps. On the flip side, CVS looks tired and is dragging a bit, with Philip Morris and Wells Fargo more mixed. Overall, the fund leans heavily into U.S. financials, health care, and big-tech value rather than a broad global spread.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Alphabet Class A | 3.78% | $6.86M | $4.12T | 44.02% | 85 Outperform | |
| Cisco Systems | 3.31% | $6.00M | $430.53B | 63.23% | 77 Outperform | |
| Microsoft | 3.24% | $5.87M | $3.71T | 0.95% | 79 Outperform | |
| Bank of America | 3.15% | $5.71M | $438.31B | 25.94% | 72 Outperform | |
| Wells Fargo | 3.12% | $5.66M | $272.07B | 13.94% | 80 Outperform | |
| Merck & Company | 3.07% | $5.58M | $370.89B | 77.46% | 80 Outperform | |
| Chevron | 2.82% | $5.12M | $412.15B | 35.75% | 71 Outperform | |
| CVS Health | 2.68% | $4.86M | $123.73B | 31.12% | 64 Neutral | |
| Philip Morris | 2.54% | $4.61M | $284.49B | 12.99% | 61 Neutral | |
| Elevance Health | 2.34% | $4.25M | $88.37B | 29.93% | 76 Outperform |
CSTK Technical Analysis
Positive
―
Price Trends
33.37
Positive
32.52
Positive
30.92
Positive
Market Momentum
0.11
Positive
52.74
Neutral
61.14
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For CSTK, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 33.86, equal to the 50-day MA of 33.37, and equal to the 200-day MA of 30.92, indicating a neutral trend. The MACD of 0.11 indicates Positive momentum. The RSI at 52.74 is Neutral, neither overbought nor oversold. The STOCH value of 61.14 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CSTK.
CSTK Peer Comparison
Comparison Results
Performance Comparison
CSTK
Invesco Comstock Contrarian Equity ETF
33.76
6.56
24.12%
GMOI
GMO International Value ETF
―
―
―
FPAG
FPA Global Equity ETF
―
―
―
MFSV
MFS Active Value ETF
―
―
―
BINV
Brandes International ETF
―
―
―
PJFV
PGIM Jennison Focused Value ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents